Accredited CME programs are no longer the only legally sanctioned forum for education about off-label uses of drugs and medical devices. In a July 30 decision, U.S. District Judge Royce C. Lamberth ruled that FDA regulations that prohibit drug and device companies from disseminating information about off-label uses are a violation of the manufacturers' commercial speech rights. The Washington Legal Foundation, a nonprofit public interest law and policy center that objects to government ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Printer-friendly, you'll also gain access to exclusive premium content.

Already registered? here.